clotrimazole (Lotrimin, Mycelex, Gyne-Lotrimin, Desenex)
Jump to navigation
Jump to search
Introduction
Oral agent: Tradename: Mycelex.
Indications
Dosage
Lozenge 5 times/day for 14 days
Lozenges: 10 mg.
Topical agent: Tradenames: Lotrimin, Mycelex.
1% cream/solution/lotion to area BID.
Monitor
- baseline liver function tests (LFTs)
- repeat LFTs in one month
Adverse effects
- common (> 10%)
- abnormal liver function tests
- less common (1-10%)
Drug interactions
- decreases metabolism of cisapride possibly leading to prolongation of the QT interval & fatal tachyarrhythmias
Mechanism of action
- alteration of the cell membrane permeability via binding of phospholipids
- fungistatic[4]
More general terms
Component of
- clotrimazole/gentamicin/mometasone
- betamethasone/clotrimazole/gentamicin
- betamethasone/clotrimazole (Lotrisone)
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ 4.0 4.1 Prescriber's Letter 9(2):11 2002
- ↑ 5.0 5.1 5.2 Deprecated Reference